Hap Trading, LLC Allakos Inc. Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $135,090 - $1.77 Million	15,800 New	15,800 $114,000
Q1 2020 May 08, 2020	SELL	$44.49 - $93.39 $449,349 - $943,239	-10,100 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$66.49 - $137.73 $1.22 Million - $2.52 Million	-18,300 Reduced 64.44%	10,100 $59,000
Q3 2019 Nov 12, 2019	BUY	$31.0 - $89.73 $880,400 - $2.55 Million	28,400 New	28,400 $131,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $20.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.